Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Broussolle

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Neurology|February 12, 2004
Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled studyF Durif, B Debilly, M Galitzky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2006
Manic behaviour induced by deep-brain stimulation in Parkinson's disease: evidence of substantia nigra implication?M Ulla, S Thobois, J-J Lemaire, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 1, 1991
Effects of substance abuse on ventricular and sulcal measures assessed by computerised tomographyN G Cascella, G Pearlson, D F Wong, et al.
Journal of Neurology|May 22, 2002
Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patientsS Thobois, P Mertens, M Guenot, et al.
Neurology|November 4, 2000
Motor imagery in normal subjects and in asymmetrical Parkinson's disease: a PET studyS Thobois, P F Dominey, J Decety, et al.
Revue Neurologique|April 20, 2020
Feasibility of changing for a rechargeable constant current neurostimulator in Parkinson's diseaseT Wirth, C Laurencin, J Berthillier, et al.
La Revue De Medecine Interne|December 31, 2002
[Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (Melas) associated with a Fahr disease and cerebellar calcifications]S Younes-Mhenni, S Thobois, N Streichenberger, et al.
Lancet (London, England)|January 14, 1995
Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulationP Limousin, P Pollak, A Benazzouz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2002
Glial toxicity in urine and multiple sclerosisC Malcus-Vocanson, P Giraud, F Micoud, et al.
European Neurology|December 5, 2002
The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulationS Thobois, S Corvaisier, P Mertens, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Neurology|February 12, 2004
Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled studyF Durif, B Debilly, M Galitzky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2006
Manic behaviour induced by deep-brain stimulation in Parkinson's disease: evidence of substantia nigra implication?M Ulla, S Thobois, J-J Lemaire, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 1, 1991
Effects of substance abuse on ventricular and sulcal measures assessed by computerised tomographyN G Cascella, G Pearlson, D F Wong, et al.
Journal of Neurology|May 22, 2002
Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patientsS Thobois, P Mertens, M Guenot, et al.
Neurology|November 4, 2000
Motor imagery in normal subjects and in asymmetrical Parkinson's disease: a PET studyS Thobois, P F Dominey, J Decety, et al.
Revue Neurologique|April 20, 2020
Feasibility of changing for a rechargeable constant current neurostimulator in Parkinson's diseaseT Wirth, C Laurencin, J Berthillier, et al.
La Revue De Medecine Interne|December 31, 2002
[Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (Melas) associated with a Fahr disease and cerebellar calcifications]S Younes-Mhenni, S Thobois, N Streichenberger, et al.
Lancet (London, England)|January 14, 1995
Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulationP Limousin, P Pollak, A Benazzouz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2002
Glial toxicity in urine and multiple sclerosisC Malcus-Vocanson, P Giraud, F Micoud, et al.
European Neurology|December 5, 2002
The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulationS Thobois, S Corvaisier, P Mertens, et al.
Pageof 11